(Q37933093)

25 August 2017

1 reference

title

Resistant hypertension: concepts and approach to management (English)

1 reference

25 August 2017

main subject

arterial hypertension

0 references

author name string

Gary E Sander

series ordinal

1

1 reference

25 August 2017

Thomas D Giles

series ordinal

2

1 reference

25 August 2017

publication date

1 October 2011

1 reference

Current Hypertension Reports

25 August 2017

published in

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

347-355

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-011-0226-7

25 August 2017

exact match

0 references

cites work

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Control of hypertension in adults with chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

The kidney, hypertension, and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Clinical practice. Resistant or difficult-to-control hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Resistant hypertension: an overview of evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Photobleaching-based method to individualize irradiation time during interstitial 5-aminolevulinic acid photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Secondary hypertension: interfering substances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Safety of herbal supplements: a guide for cardiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Interactions between herbal medicines and prescribed drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Primary aldosteronism and hypertensive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Hyperaldosteronism among black and white subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Low-renin status in therapy-resistant hypertension: a clue to efficient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Predictors of hyperkalemia risk following hypertension control with aldosterone blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Efficacy of low-dose spironolactone in subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Efficacy of spironolactone therapy in patients with true resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin-angiotensin-aldosterone system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Drug therapy for resistant hypertension: simplifying the approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Antihypertensive therapy in the presence of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Asse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Antihypertensive therapy for patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Rheos: an implantable carotid sinus stimulation device for the nonpharmacologic treatment of resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0226-7

Dihydropyridine calcium antagonists are associated with increased albuminuria in treatment-resistant hypertensives

21 January 2018

1 reference

12 December 2020

Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes

1 reference

12 December 2020

Tubular hypertrophy due to work load induced by furosemide is associated with increases of IGF-1 and IGFBP-1

1 reference

12 December 2020

Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

1 reference

12 December 2020

Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on

1 reference

12 December 2020

Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension

1 reference

12 December 2020

Do diuretics diminish the predicted benefits on ischemic heart disease events of lowering blood pressure in hypertension? Messages from ALLHAT, ACCOMPLISH, and ACCORD

1 reference

12 December 2020

Torasemide, a new potent diuretic. Double-blind comparison with furosemide

1 reference

12 December 2020

Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control

1 reference

12 December 2020

Effect of spironolactone on blood pressure in subjects with resistant hypertension

1 reference

12 December 2020

10.1007/S11906-011-0226-7

Identifiers

DOI

1 reference

25 August 2017

1 reference